mRNA therapy restores sperm production and fertility in mice
Peer-Reviewed Publication
Updates every hour. Last Updated: 2-Jan-2026 03:11 ET (2-Jan-2026 08:11 GMT/UTC)
Researchers from The University of Osaka in collaboration with Baylor College of Medicine have developed a new therapy for a severe form of male infertility called non-obstructive azoospermia (NOA). Using lipid nanoparticles (LNPs) to deliver specific mRNA into the testes of infertile mice, they were able to restart sperm production. The sperm produced were then used in intracytoplasmic sperm injection (ICSI) to successfully generate healthy and fertile offspring. The findings provide a crucial proof-of-concept for treating male infertility caused by genetic defects.
Researchers at The University of Osaka discovered that the protein TMEM217 is essential for sperm motility and male fertility. TMEM217 stabilizes a protein complex that produces the signaling molecule cAMP, which powers the sperm’s tail. Mice lacking TMEM217 have immotile sperm, but treating the sperm with a cAMP-like molecule restored motility and fertility via IVF. This finding opens doors for new diagnostics and therapies for male infertility.
Picky, pragmatic, and enigmatic — a tiny fossil found in Southwestern Virginia eluded classification for more than 514 million years. Now, Virginia Tech geoscientists have restored this unique organism into its evolutionary lineage.
U.K.-based Wellcome has awarded over €2 million to an international research effort to uncover how malaria can injure developing babies. Emanuel Wyler at the Max Delbrück Center will play a key role in studying the molecular interaction between the parasite Plasmodium falciparum and the placenta.